Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2023 | Story NONSINDISO QWABE | Photo SONIA SMALL
A jubilant gradaute

Few moments in a student’s life are as memorable as graduation day. Graduates on the Qwaqwa Campus soaked in their moment and revelled in their accomplishments during the two-day ceremonies on 14 and 15 April 2023.

Graduations on the Qwaqwa Campus are known for their unique traditional flair, and during the two-day ceremonies, the excited graduates did not disappoint. 

One thousand seven hundred and eighty-eight qualifications were awarded during the two-day ceremonies. As they walked across the stage to receive their qualifications, graduates ululated, chanted, and whipped out various traditional and modern dancing styles to celebrate their degrees. 

Graduates reminded to leave a lasting legacy

Joining the excited graduates was Prof Adipala Ekwamu, a trailblazer in the field of agriculture who was awarded an honorary doctorate on 14 April 2023 during the Natural and Agricultural Sciences graduation ceremony on our Qwaqwa Campus, and Kopung Ralikontsane, the Director General of the Department of Cooperative Governance and Traditional Affairs in the Free State, who was a guest speaker at the Faculty of Education ceremonies on Saturday 15 April 2023.

Addressing graduates during his acceptance speech, Prof Ekwamu challenged his ‘fellow graduands’ to be drivers of change in their respective industries.

“I was very impressed by the quality of the students and graduates that this university has trained. May I remind everyone that universities have always been the drivers of development and reform? Elsewhere, and in Africa too, they have contributed to the political discourse and catalysing the rate of economic development. I appeal and call upon all universities to remain the powerful drivers of innovation and environmental protection, poverty reduction, and inclusivity in all their undertakings.”

Likewise, Ralikontsane encouraged students to get involved in building the nation beyond its current limitations. Having trained as a teacher, Ralikontsane spoke about a teacher's lasting legacy as he shared his teacher reflections and gave a congratulatory speech to the graduates.

“You now have the responsibility to help our collective endeavours as a nation to improve our education, training, and innovation. I wish you to rise above the prevailing limitations of our time, insidious poverty and underdevelopment inflicted on our people, as underpinned by the principles of Batho Pele.”

The UFS wishes to congratulate our new graduates who received qualifications in ceremonies on the Qwaqwa Campus. We would like to say – Thank you for allowing us the honour to recognise your contribution to our society. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept